IMRN Immuron Limited

NASDAQ
$1.13

Immuron Limited (IMRN) is expected to report earnings on April 19, 2023, before the market open.

Earnings Date
Apr 19
Wednesday · Before Open
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Immuron Limited

Immuron Limited is a bio pharmaceutical Microbiome company. It focused on oral immunotherapy using polyclonal antibody products for humans. The company is involved in developing therapeutic products in NASH, ASH and other diseases mediated through gut disbiosis. Immuron Limited is based in Armadale, Australia.

Sector

Healthcare

Charts powered in part by Lightweight Charts™ by TradingView.